News & Resources

Effective virtual Meetings Hematology Event Case Study

Effective Virtual Meetings: A Global Online Hematology Event Case Study

The healthcare sector has been severely impacted by the coronavirus (COVID-19) outbreak. The increase in COVID-19 infections—largely due to the spread of the delta variant—is causing governments and health organizations worldwide to stay at the highest alert on high-risk social practices. Just like the rest of the world, healthcare providers are experiencing so-called “Zoom fatigue.” At the same time, a poll of 900 Nature readers (including scientists, doctors, and researchers) revealed that 74% of respondents believe scientific meetings should continue to be virtual or have a virtual component even after the pandemic ends. The challenge is how to keep virtual medical meetings engaging and, moreover, productive.

With virtual meetings, participants can access up-to-date information and network with industry professionals. As COVID-19 spreads, medical organizations can use virtual meetings to keep their schedules on track.

CASE STUDY
THE POWER OF VIRTUAL MEETINGS:
A LATAM/US VIRTUAL HEMATOLOGY EVENT

Aptitude Health completed a virtual hematology meeting for a top-5 global pharmaceutical company that included faculty members in 2 locations in the US and participants from across Latin America. This virtual educational event provided a great example of the value that digital solutions provide to clinicians and life science partners.

This broadcast occurred with live audiences in 2 different locations in Latin America and included dozens of healthcare professionals in Brazil and Argentina. Two scientific experts were presenting from Buffalo (Dr Eunice Wang) and Houston (Dr Elias Jabbour). Even across continents, the virtual platform allowed for an extremely interactive meeting with clinical presentations and over 30 questions submitted via the virtual meeting website and the live locations.

If you are facing a decision to cancel, postpone, or convert a live event to a virtual program, please contact your Aptitude Health representative or click here to learn how we can best support your business needs.

Virtual meetings preserve financial investments
Event cancellations due to COVID-19 have dealt many organizations a hard financial hit. Often, cancellations occur long after hotels and flights have been booked. Some organizations may be unable to secure a refund after a last-minute cancellation. Attendees who have paid for their travel out of pocket may also be out of luck.

With a virtual meeting platform, events can go on as planned. Organizers can rest assured that sudden outbreaks won’t interfere with their itinerary. With no need to book hotels or flights, attendees can avoid a risky investment. Virtual meetings can take place as scheduled, even if travel becomes impossible.

Virtual meetings help organizations meet sustainability goals
COVID-19 prompted recent event cancellations within the medical industry. These outbreaks have led many organizations to take a closer look at their long-term plans, as future outbreaks of infectious disease are inevitable. Natural disasters and political upheaval can also interfere with travel plans. Some professionals may also worry about the environmental impacts of frequent air travel.

Even at the best of times, holding in-person events can be expensive and unsustainable. Virtual meetings are cost-effective and eco-friendly. These tools help organizations cut costs and promote green living. In the future, virtual tools are likely to dominate over in-person sessions.

Virtual meetings are ideal for busy professionals
While no one is pleased by the recent COVID-19 outbreaks, some cancellations may come as a relief to busy HCPs. HCPs often struggle to find time for in-person conferences, training, and seminars. These events can be time-consuming, and they may interfere with patient care.

Virtual meeting platforms allow HCPs to participate from the comfort of their home or office. With virtual tools, HCPs can provide constant care to their patients; there’s no need to leave the office for time-consuming travel. Virtual meetings also offer widespread access to essential information. Shifting from in-person to virtual meetings can remove barriers that prevent participation. Sponsored by life science partners, disease-specific academies improve collaboration and communication among treating physicians and clinicians around the world to positively impact patient outcomes. Our academies provide a series of virtual educational meetings and corresponding websites featuring renowned clinical experts. Additional offerings include a resource library, ask-the-expert tool, and opportunities for continuous engagement with participants via sponsored surveys.

Live meetings are still ideal for building personal relationships, however, virtual meeting platforms offer an excellent alternative. With virtual tools, events can continue on schedule, even if the spread of COVID-19 worsens. Virtual platforms provide a safe, effective alternative to live meetings. With virtual tools, attendees reap the benefits of in-person events while safeguarding their health.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.